Found 11 matching trials
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
The First Affiliated Hospital of Zhejiang University School of Medicine
JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases
EARLY_PHASE1Early exploratory clinical study of the safety, tolerability and initial ef...
Location
Shanxi Bethune Hospital
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
The First Affiliated Hospital of Zhengzhou University
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NAhis study is an investigator-initiated single center, single arm clinical s...
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs)
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
Multiple Locations
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
Affiliated Hospital of Guangdong Medical University
JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
EARLY_PHASE1Early exploratory clinical study of the safety, tolerability and initial ef...
Location
920th HJointLogistics
JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
EARLY_PHASE1Early exploratory clinical study of the safety, tolerability and initial ef...
Location
Guangdong Second Provincial General Hospital
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
CAR-T Therapy for Refractory Autoimmune Diseases
NAThis study is an investigator-initiated single center, single arm clinical ...
Location
Wuhan No.1 Hospital